- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04492215
General Practitioners and Participation Rate in ColoRectal Cancer Screening (AMDepCCR)
Improving the Participation Rate in ColoRectal Cancer Screening by Training General Practitioners in Motivational Interviewing
Colorectal cancer is the 2nd leading cause of cancer mortality in France. However this cancer is preventable in the majority of cases by early detection of adenomas.
In France, there is organized colorectal cancer screening, which relies on general practitioners (GPs). Tests delivered by GPs are performed in 89% of cases. However, GPs do not systematically offer the test, for time management and communication reasons. Patients expect their GPs to offer the test and to focus on their expectations. A previous study conducted on GPs showed that training in communication and motivational interviewing increases the number of tests performed by 12.2%.
In order to facilitate the promotion of screening, the investigators would like to develop a training programme for GPs focusing on the application of Motivational Interviewing (MI) techniques to the promotion of colorectal cancer screening.
Motivational Interviewing is a directive, client-centered counseling style for eliciting behavior change by helping clients to explore and resolve ambivalence.
This study is a multicenter trial in general medicine. In this randomized trial the 902 subjects will be included prospectively by the general practitioners (GP) participating in the study.
As a first step, general practitioners who have never participated in Motivational Interviewing training will be recruited and split into 2 groups by randomization, an intervention group and a control group. The interventional group will then undergo a 3 times 2-day training in Motivational Interviewing.
In a second step, the patients will be included by those GP and a self-questionnaire will be send at the inclusion and after 6, 12 and 24 months. The evaluation of the number of tests performed and the analyse of the Health Belief Model (HBM) self-questionnaire will be carried out.
At 24 months, there will be an evaluation of the denial motivation questionnaire for patients who have not participated in organized colorectal cancer screening.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jean Yves Le Reste, Pr
- Phone Number: +33 02 98 01 65 52
- Email: lereste@univ-brest.fr
Study Locations
-
-
-
Brest, France, 29200
- Not yet recruiting
- Dr ABALAIN
-
Contact:
- Aurélie ABALAIN, Dr
-
Brest, France, 29200
- Recruiting
- Dr HENRY
-
Contact:
- Pierre HENRY, Dr
-
Brest, France, 29200
- Not yet recruiting
- Dr PETTON-HILI
-
Contact:
- Anne-Laure PETTON-HILI, Dr
-
Châteauneuf-du-Faou, France, 29520
- Not yet recruiting
- Dr DENIEL
-
Contact:
- Magalie DENIEL, Dr
-
Châteauneuf-du-Faou, France, 29520
- Not yet recruiting
- Dr LE BOURHIS
-
Contact:
- Erwan LE BOURHIS, Dr
-
Clohars-Carnoët, France, 29360
- Not yet recruiting
- Dr PERRIER
-
Contact:
- Isabelle Clohars-Carnoët, Dr
-
Crozon, France, 29160
- Not yet recruiting
- Dr CHAPOIX
-
Contact:
- Nicolas CHAPOIX, Dr
-
Daoulas, France, 29460
- Not yet recruiting
- Dr OLIVIER
-
Contact:
- Eric OLIVIER, Dr
-
Douarnenez, France, 29100
- Not yet recruiting
- Dr ATTENCOURT
-
Contact:
- Christophe ATTENCOURT, Dr
-
Douarnenez, France, 29100
- Not yet recruiting
- Dr KERVELLA
-
Contact:
- Sylvie KERVELLA, Dr
-
Ergué-Gabéric, France, 29500
- Not yet recruiting
- Dr VELLY
-
Contact:
- Jean-François VELLY, Dr
-
Esquibien, France, 29770
- Not yet recruiting
- Dr BLANCHARD
-
Contact:
- Julie BLANCHARD, Dr
-
Esquibien, France, 29770
- Not yet recruiting
- Dr DESNOT
-
Contact:
- Richard DESNOT, Dr
-
Esquibien, France, 29770
- Not yet recruiting
- Dr VIALA
-
Contact:
- Jeanlin VIALA, Dr
-
Fouesnant, France, 29170
- Not yet recruiting
- Dr DAOUDAL
-
Contact:
- Aurore DAOUDAL, Dr
-
Fouesnant, France, 29170
- Not yet recruiting
- Dr LEFEVRE
-
Contact:
- Maxime LEFEVRE, Dr
-
Fouesnant, France, 29170
- Not yet recruiting
- Dr MAGADUR
-
Contact:
- Véronique MAGADUR, Dr
-
Guerlesquin, France, 29650
- Not yet recruiting
- Dr MUNCK
-
Contact:
- Pauline MUNCK, Dr
-
Guerlesquin, France, 29650
- Not yet recruiting
- Dr POINOT
-
Contact:
- Anne POINOT, Dr
-
Guilvinec, France, 29730
- Not yet recruiting
- Dr LE FLOCH
-
Contact:
- Bernard LE FLOCH, Dr
-
Guisseny, France, 29880
- Not yet recruiting
- Dr LE GRIGNOU
-
Contact:
- Caroline LE GRIGNOU, Dr
-
Landivisiau, France, 29400
- Not yet recruiting
- Dr PITMAN
-
Contact:
- Roberto PITMAN, Dr
-
Lanmeur, France, 29260
- Not yet recruiting
- Dr COLLETER
-
Contact:
- Manuel COLLETER, Dr
-
Lanmeur, France, 29260
- Not yet recruiting
- Dr CRENN-CORVEZ
-
Contact:
- Hélène CRENN-CORVEZ, Dr
-
Lanmeur, France, 29620
- Not yet recruiting
- Dr BECK-ROBERT
-
Contact:
- Emilie BECK-ROBERT, Dr
-
Lannilis, France, 29870
- Not yet recruiting
- Dr BARAIS
-
Contact:
- Marie BARAIS, Dr
-
Le Conquet, France, 29217
- Not yet recruiting
- Dr VERBEQUE MORVAN
-
Contact:
- Manon VERBEQUE MORVAN, Dr
-
Le Faou, France, 29590
- Not yet recruiting
- Dr TREBAOL
-
Contact:
- Emmanuelle TREBAOL, Dr
-
Le Relecq-Kerhuon, France, 29480
- Not yet recruiting
- Dr GRALL
-
Contact:
- Olivier GRALL, Dr
-
Loperhet, France, 29470
- Not yet recruiting
- Dr BOUTERAON
-
Contact:
- Sylvie BOUTERAON, Dr
-
Moelan Sur Mer, France, 29350
- Not yet recruiting
- Dr PIPET-PENIN
-
Contact:
- Gaëlle PIPET-PENIN, Dr
-
Pleyben, France, 29190
- Not yet recruiting
- Dr BEURTON-COURAUD
-
Contact:
- Lucas BEURTON-COURAUD, Dr
-
Pleyben, France, 29190
- Not yet recruiting
- Dr LUCAS
-
Contact:
- Aldric LUCAS, Dr
-
Pleyber-Christ, France, 29410
- Not yet recruiting
- Dr KERFRIDEN KERHOAS
-
Contact:
- Morgane KERFRIDEN KERHOAS, Dr
-
Plonévez-Porzay, France, 29550
- Not yet recruiting
- Dr BAUTA
-
Contact:
- Vincent BAUTA, Dr
-
Plonévez-Porzay, France, 29550
- Not yet recruiting
- Dr COGNEAU
-
Contact:
- Clément COGNEAU, Dr
-
Ploudalmezeau, France, 29830
- Not yet recruiting
- Dr GASNIER
-
Contact:
- Anne-Laure GASNIER, Dr
-
Plouezoc'h, France, 29252
- Not yet recruiting
- Dr AOUDIA
-
Contact:
- Seddik AOUDIA, Dr
-
Plougonven, France, 29640
- Not yet recruiting
- Dr LOPIN
-
Contact:
- Céline LOPIN, Dr
-
Plouhinec, France, 29780
- Not yet recruiting
- Dr DROGOU
-
Contact:
- Marine DROGOU, Dr
-
Plouneour Trez, France, 29890
- Not yet recruiting
- Dr BODIN
-
Contact:
- Bénédicte BODIN, Dr
-
Plouzané, France, 29280
- Not yet recruiting
- Dr DE LA SOUDIERE
-
Contact:
- Ségolène DE LA SOUDIERE, Dr
-
Pont l'Abbé, France, 29120
- Not yet recruiting
- Dr PETIT
-
Contact:
- Elisabeth PETIT, Dr
-
Pouldreuzic, France, 29710
- Not yet recruiting
- Dr PREVOT
-
Contact:
- Jeanne PREVOT, Dr
-
Quimper, France, 29000
- Not yet recruiting
- Dr AUTRET
-
Contact:
- Hervé AUTRET, Dr
-
Quimper, France, 29000
- Not yet recruiting
- Dr COROLLER
-
Contact:
- Philippe COROLLER, Dr
-
Quimper, France, 29000
- Not yet recruiting
- Dr COUTURIER
-
Contact:
- Thomas COUTURIER, Dr
-
Quimper, France, 29000
- Not yet recruiting
- Dr JOLIVET COUTURE
-
Contact:
- Anne JOLIVET COUTURE, Dr
-
Quimper, France, 29000
- Not yet recruiting
- Dr KERGASTEL
-
Contact:
- Hélène KERGASTEL, Dr
-
Saint-Martin-des-Champs, France, 29600
- Not yet recruiting
- Dr BARCELO
-
Contact:
- Luc BARCELO, Dr
-
Spezet, France, 29540
- Not yet recruiting
- Dr MAILLEUCHET
-
Contact:
- Jean-François MAILLEUCHET, Dr
-
St Yvi, France, 29140
- Not yet recruiting
- Dr MONFORT
-
Contact:
- Xavier MONFORT, Dr
-
Trégunc, France, 29910
- Not yet recruiting
- Dr NICOLAS
-
Contact:
- Anne-Catherine NICOLAS, Dr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- People with an average risk of colorectal cancer (presenting no symptoms or risk factors).
- People living in Finistère.
- People aged 50 to 74 who have never participated in organized screening for colorectal cancer.
Exclusion Criteria:
- Persons without address to receive the Health Belief Model (HBM)questionnaire
- People who do not fit the organized screening criteria
- Persons unable to give consent (patients under guardianship, curatorship, non-French speaking, illiterate)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Physicians trained in motivational interviewing
Patients followed by general practitioners trained in motivational interviewing
|
Impact of the medical interview on the patient
Other Names:
|
No Intervention: Physicians did not trainned in motivational interviewing
Patients followed by general practitioners who did not receive motivational interviewing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of organised colorectal cancer screening at 24 months
Time Frame: 24 months
|
The impact of training general practitioners in motivational interviewing on the rate of organised colorectal cancer screening will be assessed by determining whether or not the immunological test proposed as part of organised colorectal cancer screening at 24 months will be carried out.
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of organised colorectal cancer screening at 12 months
Time Frame: 12 months
|
Whether or not to perform the proposed immunological test as part of organized colorectal cancer screening at 12 months.
|
12 months
|
Changes in perceptions of colorectal cancer screening
Time Frame: Day 0, 6 months, 12 months and 24 months
|
Changes in perceptions of colorectal cancer screening will be assessed using a Health Belief Model (HBM). The Health Belief Model (HBM) is a social psychological health behavior change model developed to explain and predict health-related behaviors, particularly in regard to the uptake of health services. This Health Belief Model use for this study evaluate : individual perceptions (perceived susceptibility and severity), modifying factors (perceived threat and cues to action) and likelihood of action (perceived benefit and perception barriers and taking health action) at Day 0, Month 6, Month 12 and Month 24. |
Day 0, 6 months, 12 months and 24 months
|
Evolution of the self-assessment of life expectancy
Time Frame: Day 0, 6 months, 12 months and 24 months
|
Patients will answer a question to find out their self-assessment of life expectancy.
|
Day 0, 6 months, 12 months and 24 months
|
Identification of denial of the colorectal cancer screening
Time Frame: 24 months
|
Understand why patients refuse colorectal cancer screening of by identificating et quantificating reasons why the patient did not realised the colorectal cancer screening at 24 months of follow up.
|
24 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 29BRC19.0115 (AMDepCCR)
- 2019-A01776-51 (Other Identifier: IDRCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Adenocarcinoma | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCancer Survivor | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal Cancer AJCC v8 | Stage IIB Colorectal... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...United States Department of DefenseActive, not recruitingColorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditionsUnited States
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
University of Roma La SapienzaCompletedColorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage IItaly
-
University of Southern CaliforniaNational Cancer Institute (NCI); AmgenTerminatedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...United States
Clinical Trials on Interaction between patient and trained general practitioners in motivational interviewing
-
Michael Garron HospitalUniversity of Toronto; Ontario Ministry of Health and Long Term Care; Southlake...CompletedChronic Obstructive Pulmonary Disease | Multiple ComorbidityCanada